Skip to main content
. 2021 May 6;13:624330. doi: 10.3389/fnagi.2021.624330

Figure 9.

Figure 9

Representative images of T1WI MRI and [18F]SynVesT-1 PET of a [18F]Florbetapir positive AD patient. SV2A binding is significantly reduced in the left hippocampus (white arrow). Images provided by PET Center, Huashan Hospital, Fudan University and Department of Nuclear Medicine, East Hospital, Tongji University.